At Direction of U.S. Appeals Court, Judge Issues Amended Judgement in Lilly’s 340B Contract Pharmacy Case

Senior District Court Judge Sarah Evans Barker
It is unknown whether U.S. Senior District Judge Sarah Evans Barker’s amended partial final judgement in Lilly's 340B contract pharmacy lawsuit will satisfy a higher court that kicked the case back to her.

A federal district judge in Indianapolis last week responded to a higher court’s directive and entered an amended partial final judgement in drug manufacturer Lilly’s 340B contract pharmacy lawsuit. It is not clear whether the judge did enough to satisfy

Read More »

Sanofi Makes Two Big Changes to its 340B Contract Pharmacy Policy

Sanofi outdoor building sign
Changes to Sanofi's 340B drug pricing conditions may eliminate 340B discounts for health centers using multiple contract pharmacies within a chain.

Drug manufacturer Sanofi has made two major changes to its conditions on 340B pricing when health centers and certain hospitals and use contract pharmacies, a company spokesperson confirms. One is raising flags among 340B providers and the other appears to

Read More »

BMS Fleshes Out How It Will Use Claims Data for 340B Myeloma Drug Purchases

Bristol Myers Squibb exterior sign
BMS has released its terms of use for the claims data providers must give it in exchange for access to 340B pricing on Revlimid, Pomalyst, and Thalomid.

Bristol Myers Squibb has disclosed its terms of use for the drug claims data that providers must give it in exchange for access to 340B pricing on BMS’s oral oncology drugs Revlimid, Pomalyst, and Thalomid.

BMS acquired the three drugs

Read More »

340B Providers Say Express Scripts’ New 340B Claims Validation Requests Raise Red Flags

Express Scripts office building
340B covered entities have raised concerns about Express Scripts' new requests to verify 340B drug reimbursement claims.

340B hospitals and health centers say they have a lot of questions about new requests from Express Scripts (ESI) to verify 340B drug reimbursement claims in 10 business days.

Hospital and health center covered entities report getting one or more

Read More »

Feds Tell Court Tennessee Health System Paid for Referrals to Recoup “Staggering” 340B Discounts

Methodist University Hospital building mounted sign
The federal government told a court this week that Methodist Le Bonheur Healthcare agreed to pay a private oncology practice "for referrals and the opportunity to recoup discounts through the 340B program." Methodist has vowed to vigorously defend itself against what it says are meritless claims.

The federal government on Monday accused a Tennessee health system of unlawfully paying a Memphis-area private oncology practice for patient referrals, letting the system “recoup a staggering discount in costs” through the 340B program. The 340B health system—Methodist Le Bonheur

Read More »

Feds Appeal Court Ruling in AstraZeneca’s 340B Contract Pharmacy Lawsuit

AstraZeneca building sign
The federal government is appealing a lower court's ruling in AstraZeneca’s 340B contract pharmacy lawsuit.

The federal government, as expected, is challenging a federal district judge’s February opinion and March final orders in drug manufacturer AstraZeneca’s 340B contract pharmacy lawsuit.

The U.S. Justice Department (DOJ) announced the appeal in a one-sentence court filing on April

Read More »

Today Is Last Day for Some Hospitals to File Paperwork for 340B Reinstatement

screenshot of HRSA 340B drug pricing program
Today is the last day for hospitals that have lost their 340B eligibility during the COVID-19 pandemic to file paperwork to be reinstated to the drug discount program.

Today is the last day for hospitals that have lost their 340B eligibility due to the COVID-19 public health emergency to file paperwork to be reinstated to the drug discount program.

A federal spending bill signed on March 15 included 

Read More »

COVID-19 Public Health Emergency Extended Through July 15

COVID-19 public health emergency sign

U.S. Health and Human Services Secretary Xavier Becerra has extended the COVID-19 public health emergency for another 90 days, through July 15. It was due to end on Saturday, April 16.

Major hospital groups and group purchasing organizations asked Becerra

Read More »

Astellas Providing Refunds for 340B Overcharges from Q3 2020 Through Q2 2021

Astellas building mounted sign
Astellas is issuing 340B covered entities refunds for overcharges on Xtandi and Myrbetriq for the period from Q3 2020 through Q2 2021.

Astellas Pharma is issuing 340B covered entities refunds for overcharges on three NDCs for its prostate cancer treatment Xtandi and on four NDCs for its overactive bladder medication Myrbetriq for the period from Q3 2020 through Q2 2021.

Astellas posted 

Read More »

Multiple Developments in 340B Contract Pharmacy Lawsuit Appeals

plaintiff table in a courtroom
There has been a burst of activity in federal appeals courts in drug manufacturers' 340B contract pharmacy lawsuits.

A federal appeals court in Chicago has told a lower court in Indianapolis to issue a final judgement in drug manufacturer Lilly’s 340B contract pharmacy lawsuit to clear the way for the case’s next phase.

An appeals court in Philadelphia

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live